ALK gene copy number gain and its clinical significance in hepatocellular carcinoma

Table 1 Clinicopathological characteristics of hepatocellular carcinoma patients n (%)

Characteristics	Patients
Total	213 (100)
Age (yr)a
< 49	105 (49.3)
≥ 49	108 (50.7)
Sex
Female	17 (8.0)
Male	196 (92.0)
Grade
I	19 (8.9)
II	97 (45.5)
III	91 (42.7)
IV	6 (2.8)
Stage
I + II	174 (81.7)
III + IV	39 (18.3)
Relapse
No	83 (39.0)
Yes	130 (61.0)
AFP (ng/mL)
< 400	125 (58.7)
≥ 400	88 (41.3)
Child-Pugh classification
A	195 (91.5)
B	16 (7.5)
C	2 (0.9)
HBV DNA
Positive	113 (53.1)
Negative	100 (46.9)
Postoperative platelet count
< 100 × 109/L	35 (16.4)
≥ 100 × 109/L	178 (83.6)

^aMedian: 49, range: 25-75 years. AFP: Alpha fetoprotein; HBV: Hepatitis B virus.